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1206-71 Equivalence of Bioimpedance and Thermodilution in 
Measuring Cardiac Output and Index in Patients With 
Advanced, Decompensated Chronic Heart Failure 
Hospitalized in Critical Care 
Nancv M. Albert, Melanie D. Hail, Jianbo LI, James B. Young, The Cleveland Clinic 
Foundation, Cleveland, OH 
Background: An accurate and reliable technique for non-invasive measurement of car- 
diac oufput (CO)/catdiac index (Cl) could be valuable in the clinical management of 
acutely decompensated patients with advanced systolic heart failure. Perhaps imped- 
ance cardiography (ICG) would reduce morbidity and overall costs associated with use of 
pulmonary artery catheters (PAC). CO/Cl by ICG has strong correlation and level of 
agreement to thermodilution (TD) in patients with stable, mild-advanded HF, however, it 
is unknown if the methods correlate in acutely decompensated complex patients requir- 
ing critical care management. 
Methods: 33 critically ill patients with PAC’s had ICG applied by Bio-Z@. CO/Cl were 
obtained by both methods with patients in supine position. Measurement and recording 
of TD and ICG was counterbalanced in patients. Published consensus guidelines were 
used for TO technique Echo and electrocardiographic data were recorded to determine if 
differences between techniques could be explained by findings associated with 
advanced condition. Pearson’s correlation coefficient and agreement between methods 
by Bland and Altman were calculated. 
Results: 4 patients were excluded from analysis because ICG measurements were not 
reliably obtained per Bio-Z monitor messages. In 29 patients, mean left ventricular ejec- 
tion fraction was16.8 f 7.4%. 34% of patients had 3.4+ mitral regurgitation and 24% had 
3.4+ tricuspid regurgitation. Intravenous agents included inotropic, 45%; vasodilators. 
31%; and inovasodilator, 14%. Pacemakers were present in 41% and cardiowter- 
defibrillator in 34% of patients. Mean CO by TO and ICG was 5.48 and 5.40 Umin (r 
=0.69, P < 0.0001). Mean Cl by TO and ICG was 2.67 and 2.65 Umin/m* (r = 0.62.P < 
O.Oml). Mean bias (limits of agreement) between data pairs for CO was 0.06 (-0.16 to 
0.34) Umin (P= 0.52) and for Cl was 0.03 (-0.097 to 0.16) Umin/m’ (PC 0.61). Five data 
pairs (17%) had an absolute percent difference > 15%. Of these, 60% had a higher bolus 
reading. 
Conclusion: CO/Cl in ICG and TO were significantly correlated. Mean bias between 
methods was highly favorable, reflecting clinical utility in hospitalized patients with com- 
plex decompensated heart fallwe. 
1206-72 Right Ventricular Functional Reserve Measured by en 
Implanted Hemodynamic Monitor Correlates With 
Exercise ENP Levels 
Wael S. Abo-Auda, Brian A. Foley, Barbro M. Kjellstrom, Tom D. Bennett, Mathew 
Cavender, Raymond L. Benza, Barry K. Rayburn, Jose A. Tallai, Laura Pinderski, Phillp 
Johnson, Robert C. Bourge, The University of Alabama at Birmingham, Birmingham, AL 
Objective: We investigated the relationship of right ventricular (RV) exercise hemody- 
namxs to BNP in patients (pt) with severe congestive heart failure (CHF) with a chroni- 
cally implanted hemodynamic monitor (IHM) (Medtronlc; Chronicle@). 
Background: RV function is a predictor of survival 8 exercise capacity in pt with (CHF). 
Little is known regarding a relationship of BNP to exercise RV hemodynamics. 
Methods: Four pt, NYHA Class III CHF, with an IHM had 6 treadmill exercise studies. RV 
hemodynamic data was obtained from the IHM, then direct 8 derived hemodynamic data 
were analyzed in relation to rest and exercise BNP levels. 
Results: BNP level was 301 * 261 pg/ml at baseline (BNP-B) & increased to 356 + 269 
pglml at peak exercise (BNP-P) (p=O.O25). Baseline RV pulse pressure (RVPP) & dP/ 
d&, were 26.5 * 11.5 mmHg & 359 * 112 mmHg/s respectively. At peak exercise, 
RVPP Increased by 21 * 6.9 (p=O.OOl) & dP/dt,,, by 561 + 173 (p=O.OOl). A positive 
correlation was noted among indices of RV functional reserve (FR) (change in RVPP & 
dP/d&, with exercise) (r = .61, p=O.Ol). BNP-P showed inverse correlation with dP/ 
d&, (r= -.69, p=O.O19) & RVPP (r= -.95, p=O.O04) (graph). 
Correlation: r = - 0.9503 , p=O.O036 
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Conclusions: Hemodynamlcally derived indlces of RV FR may be assessed with an 
IHM in pt with severe CHF. Plasma BNP levels increase slightly with exercise, and corre- 
late inversely with indices of RV FR 
1206-73 Monitoring ofthe Internal Thoracic Impedance: A Novel 
Method to Detect Pulmonary Edema Before Appearance 
of Clinical Signs 
Michael Shochat, Simha Meisel, Pave1 Rabinovich, Benny Peled. Hillel Yaffe Medical 
Center, Hadera, Israel 
Background monitoring of patients at high-risk to develop cardiogenic pulmonary 
edema (CPE) in order to predict its appearance is presently not employed due to the low 
sensitivity of existing methods. To overcome this problem we proposed a more sensitwe 
method based on the measurement of the internal thoracic impedance (ITI). ITI 
decreases on evolving CPE due to increased lung water content leading to a decrease of 
its resistance.Methods: ITI. degree of crepitatons, heart and respiratory rate and pulse 
oximetry were measured in 257 patients every 30 mmutes for 24 hours aHer admission 
for acute myocardial infarction. None of the patients had any signs of CPE at the begin- 
ning of monitoring. 
Results two hundred twenty seven patients did not develop CPE (group 1) while 30 
patients developed CPE during monitoring (group 2). Initial ITI in group 1 was 62.5* 14.5 
ohms and in group 2 it measured 60.1i9.6 ohms (p=O.45). ITI decrease during 24 hours 
of monitoring in group1 was 3.6+3.0% of initial value (range 0% to -10%). In group 2 ITI 
decreased significantly by 10.2+3.5% (range -5.4% to -17.4%) at 60 minutes before the 
appearance of crepitations. At 30 min before the appearance of clinical signs ITI 
decreased by 16.7*2.7% from initial level (range 12% - 24%). At the time of the appear- 
ance of clinical signs in group 2 ITI decreased from initial value by 21*3.5% on average 
(range 15-27%).All these changes were statistically significant. We assessed the suit- 
ability of each measurable parameter to predict CPE 30 minutes before its clinical detec- 
tion. AUC for ITI was 0.996, for respiratory rate 0.62, for heart rate 0.56 and for pulse 
oximetry 0.54. 
Conclusion: These data show that in patients at risk to develop CPE an ITI decrease of 
more than 10% from the Initial value indicates that these patients may be in the early 
stage of CPE development. ITI monitoring by this novel sensitive method enables the 
detection of CPE at the very early stage of its evolution before the appearance of clinical 
signs. 
1206-74 Noninvasive VeriCor System Has Less Error Than the 
Pulmonary Artery Catheter in Measuring Lefi 
Ventricular End-Diastolic Pressure 
G.v.r.k. Sharma Patricia A. Woods, Frederick W. Welt, Thomas P. Rocco, Kevin M. 
McIntyre, Peter Sacchetti, Boston VA Healthcare System, West Roxbury, MA, Harvard 
Medical School, Boston, MA 
Background: VeriCor is a non-invasive system that analyzes the artenal pressure 
response to the strain phase of the Valsalva maneuver to determme the left ventricular 
end-diastolic pressure (LVEDP). 
Methods: We compared the relative error of VeriCor and the pulmonary artery (PA) cath- 
eter-measured pulmonary capillary wedge pressure in estimating the “true” LVEDP mea- 
sured by a IeH ventricular catheter in 62 patients undergoing elective left heart 
cathetenzatlon. 
Results: 
Dewatlon from “true’ 
LVEDP 
Cumulative Measurements (%) differing from “true’ 
LVEDP 
mmHg VeriCor PA Catheter 
>l .o 74 61 
>3.0 49 65 
>s.o 9 37 
>7.0 3 14 
>9.0 0 5 
* 
* 
Conclusion: At every level of deviation from “true” LVEDP (>l .O to 
>S.OmmHg) fewer VeriCor measurements differ from “true” LVEDP than PA- 
catheter estimates. Since the error of PA catheter estimates increases pro- 
gressively as the LVEDP increases,VeriCor may have an advantage in the 
treatment of patients with congestive heart failure. 
1206-75 f32-Adrenoceptor Polymorphism: A Potential Role in 
Modulating Pulmonary Function in Heart Failure 
Robed Walk, Virend K. Somers, Stephen T. Turner, Lyle Olson, Bruce Johnson, Mayo 
Clinic. Rochester, MN 
BACKGROUND. Beta2-adrenoceptors regulate pulmonary function. Heart failure (CHF) 
is associated with activation of the adrenergic system and beta2-adrenoceptor desensiti- 
zation. as well as with abnormalities of pulmonary function. Genetic polymorphisms of 
